Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case.
暂无分享,去创建一个
Salvador Ventura | Fabrizio Chiti | Francesc X Aviles | Luis Serrano | Christopher M Dobson | Ramón Mangues | C. Dobson | L. Serrano | B. Reif | E. Giannoni | F. Chiti | J. Zurdo | R. Mangues | F. Avilés | S. Ventura | Bernd Reif | Saravanakumar Narayanan | M. Parreño | Jesús Zurdo | Saravanakumar Narayanan | Matilde Parreño | Elisa Giannoni
[1] Jörg Gsponer,et al. Molecular dynamics simulations of protein folding from the transition state , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[2] Christopher M. Dobson,et al. Protein-misfolding diseases: Getting out of shape , 2002, Nature.
[3] E. Mandelkow,et al. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] S. Betts,et al. Mutational effects on inclusion body formation. , 1997, Advances in protein chemistry.
[5] J. Richardson,et al. Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Otzen,et al. Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. Mulkerrin,et al. pH dependence of the reversible and irreversible thermal denaturation of gamma interferons. , 1989, Biochemistry.
[8] P. S. Kim,et al. Measurement of the β-sheet-forming propensities of amino acids , 1994, Nature.
[9] Fabrizio Chiti,et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Bernhagen,et al. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. , 2000, Journal of molecular biology.
[11] R. Ellis,et al. Medicine: Danger — misfolding proteins , 2002, Nature.
[12] L. Regan,et al. A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] Luis Serrano,et al. Elucidating the folding problem of helical peptides using empirical parameters , 1994, Nature Structural Biology.
[14] I D Campbell,et al. Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[15] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[16] M. Hecht,et al. Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis. , 2000, Journal of molecular biology.
[17] Peer Bork,et al. SMART: identification and annotation of domains from signalling and extracellular protein sequences , 1999, Nucleic Acids Res..
[18] L Serrano,et al. Development of the multiple sequence approximation within the AGADIR model of alpha-helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms. , 1997, Biopolymers.
[19] M. Hurle,et al. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4. , 1995, Biochemistry.
[20] Andreas Hoenger,et al. De novo designed peptide-based amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[21] L. Tjernberg,et al. Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Hecht,et al. De novo amyloid proteins from designed combinatorial libraries. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] Kresten Lindorff-Larsen,et al. Calculation of mutational free energy changes in transition states for protein folding. , 2003, Biophysical journal.
[24] D Baker,et al. Long-range order in the src SH3 folding transition state. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] C. Dobson. Protein Folding and Disease: a view from the first Horizon Symposium , 2003, Nature Reviews Drug Discovery.
[26] J. Kelly,et al. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. , 1998, Current opinion in structural biology.
[27] Elena Orlova,et al. Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.
[28] W. Kabsch,et al. Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.
[29] L Serrano,et al. Protein engineering as a strategy to avoid formation of amyloid fibrils , 2000, Protein science : a publication of the Protein Society.
[30] James C. Sacchettini,et al. Therapeutic strategies for human amyloid diseases , 2002, Nature Reviews Drug Discovery.
[31] J. King,et al. Frequencies of amino acid strings in globular protein sequences indicate suppression of blocks of consecutive hydrophobic residues , 2001, Protein science : a publication of the Protein Society.
[32] S. Aota,et al. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. , 1998, Journal of molecular biology.
[33] Vijay S Pande,et al. Sequence optimization for native state stability determines the evolution and folding kinetics of a small protein. , 2003, Journal of molecular biology.
[34] Christopher M. Dobson,et al. Amyloid fibrils from muscle myoglobin , 2001, Nature.
[35] L. Serrano,et al. Insights into the origin of the tendency of the PI3-SH3 domain to form amyloid fibrils. , 2002, Journal of molecular biology.
[36] Y. Kallberg,et al. Prediction of Amyloid Fibril-forming Proteins* , 2001, The Journal of Biological Chemistry.
[37] J. Zurdo,et al. Competing intrachain interactions regulate the formation of β‐sheet fibrils in bovine PrP peptides , 2003, Protein science : a publication of the Protein Society.
[38] P. Lansbury,et al. Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.
[39] M. Picken,et al. The changing concepts of amyloid. , 2009, Archives of pathology & laboratory medicine.
[40] Christopher M. Dobson,et al. Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.
[41] Christopher M Dobson,et al. Exploring amyloid formation by a de novo design. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[42] J. Pettegrew,et al. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[43] C. Dobson,et al. Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. , 2001, Journal of molecular biology.
[44] J Schultz,et al. SMART, a simple modular architecture research tool: identification of signaling domains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[45] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[46] C. Dobson. Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.
[47] C. Dobson,et al. Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.
[48] L. Serrano,et al. Non-native local interactions in protein folding and stability: introducing a helical tendency in the all beta-sheet alpha-spectrin SH3 domain. , 1997, Journal of molecular biology.
[49] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[50] I. Campbell,et al. Solution structure and ligand-binding site of the SH3 domain of the p85α subunit of phosphatidylinositol 3-kinase , 1993, Cell.
[51] R. Wetzel. Mutations and off-pathway aggregation of proteins. , 1994, Trends in biotechnology.
[52] C. Dobson,et al. Altered aggregation properties of mutant γ‐crystallins cause inherited cataract , 2002 .
[53] Stefan M. Larson,et al. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures , 2000, Protein science : a publication of the Protein Society.
[54] M. Hecht,et al. Rationally designed mutations convert de novo amyloid-like fibrils into monomeric β-sheet proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[55] Christine Wurth,et al. Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis. , 2002, Journal of molecular biology.
[56] C. Dobson,et al. Preparation and characterization of purified amyloid fibrils. , 2001, Journal of the American Chemical Society.
[57] L Serrano,et al. Elucidating the folding problem of alpha-helices: local motifs, long-range electrostatics, ionic-strength dependence and prediction of NMR parameters. , 1998, Journal of molecular biology.